Narrowing the difference in dose delivery for IOERT and IOBT for locally advanced and locally recurrent rectal cancer
- PMID: 36199944
- PMCID: PMC9528825
- DOI: 10.5114/jcb.2022.118305
Narrowing the difference in dose delivery for IOERT and IOBT for locally advanced and locally recurrent rectal cancer
Abstract
Purpose: Intra-operative radiotherapy (IORT) has been used as a tool to provide a high-dose radiation boost to a limited volume of patients with fixed tumors with a likelihood of microscopically involved resection margins, in order to improve local control. Two main techniques to deliver IORT include high-dose-rate (HDR) brachytherapy, termed 'intra-operative brachytherapy' (IOBT), and electrons, termed 'intra-operative electron radiotherapy' (IOERT), both having very different dose distributions. A recent paper described an improved local recurrence-free survival favoring IOBT over IOERT for patients with locally advanced or recurrent rectal cancer and microscopically irradical resections. Although several factors may have contributed to this result, an important difference between the two techniques was the higher surface dose delivered by IOBT. This article described an adaptation of IOERT technique to achieve a comparable surface dose as dose delivered by IOBT.
Material and methods: Two steps were taken to increase the surface dose for IOERT: 1. Introducing a bolus to achieve a maximum dose on the surface, and 2. Re-normalizing to allow for the same prescribed dose at reference depth.
Conclusions: We describe and propose an adaptation of IOERT technique to increase surface dose, decreasing the differences between these two techniques, with the aim of further improving local control. In addition, an alternative method of dose prescription is suggested, to consider improved comparison with other techniques in the future.
Keywords: dose distribution; dosimetry; intraoperative brachytherapy; intraoperative electron radiotherapy; intraoperative radiotherapy; locally advanced rectal cancer; recurrent rectal cancer; surface dose.
Copyright © 2022 Termedia.
Conflict of interest statement
The authors report no conflict of interest.
Figures
References
-
- Holm T, Cedermark B, Rutqvist LE. Local recurrence of rectal adenocarcinoma after ‘curative’ surgery with and without preoperative radiotherapy. Br J Surg 1994; 81: 452-455. - PubMed
-
- MacFarlane JR, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993; 341: 457-460. - PubMed
-
- Kapiteijn E, Marijnen CA, Nagtegaal IDet al. . Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-646. - PubMed
-
- Sauer R, Becker H, Hohenberger Wet al. . Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740. - PubMed
-
- Mohiuddin M, Marks G, Marks J. Long-term results of reirradiation for patients with recurrent rectal carcinoma. Cancer 2002; 95: 1144-1150. - PubMed
LinkOut - more resources
Full Text Sources